AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
AtaiBeckley Inc., a clinical-stage biotech company focused on innovative mental health treatments, announced its participation in several investor conferences throughout June 2026. Management will present company updates and pipeline progress in fireside chats and one-on-one meetings, with webcasts available to the public. The company's pipeline in…